Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock
-
Total 13F shares
-
303,518
-
Share change
-
+61,324
-
Total reported value
-
$266,000
-
Price per share
-
$0.90
-
Number of holders
-
11
-
Value change
-
+$52,953
-
Number of buys
-
5
-
Number of sells
-
1
Institutional Holders of iBio, Inc. - Common Stock (IBIO) as of Q1 2019
As of 31 Mar 2019,
iBio, Inc. - Common Stock (IBIO) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
303,518 shares.
The largest 10 holders included
VANGUARD GROUP INC, CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, Virtu Financial LLC, BlackRock Inc., TWO SIGMA SECURITIES, LLC, NORTHERN TRUST CORP, HighTower Advisors, LLC, UBS Group AG, and ROYAL BANK OF CANADA.
This page lists
11
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.